GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncology Pharma ONPH ยท USD

Health Care ยท US listing ยท ๐Ÿ‡บ๐Ÿ‡ธ United States

Compare

0.04

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Oncology Pharma โ€” daily ONPH Delayed
Volume
8.5k
Shares, 9 Nov 2026

About Oncology Pharma

Its shares trade under the ticker ONPH. It has been listed since 8 April 1994.

Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company is headquartered in San Francisco, California. The firm is focused on developing, manufacturing and commercialization of therapeutics. The Companyโ€™s portfolio includes Nanosmart Pharmaceuticals and Tulynode. Tulynode is an autologous cellular immune-therapy extracorporeal device. The Companyโ€™s NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors.

Figures and description from our data supplier, not checked against the company's own report.

More about Oncology Pharma โ†’

Latest on Oncology Pharma

Our reporting

We have not reported on Oncology Pharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

โ€”

Return

โ€”

Leaves out fees, taxes and financing.

Frequently asked questions

What is Oncology Pharma's ticker?

Oncology Pharma trades as ONPH on its US listing, under ISIN US68235J2015.

What was Oncology Pharma's last closing price?

0.04 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.